Nephroprotective Effect of Embryonic Stem Cells Reducing Lipid Peroxidation in Kidney Injury Induced by Cisplatin

Overview

Journal Oxid Med Cell Longev

Publisher Wiley

Specialties Cell Biology
Endocrinology

Date 2019 Apr 20

PMID 31001374

Citations 11

Authors

Monica Maribel Mata-Miranda

Carlos Eduardo Bernal-Barquero

Adriana Martinez-Cuazitl

Carla Ivonne Guerrero-Robles

Virginia Sanchez-Monroy

Marlon Rojas-Lopez

Gustavo Jesus Vazquez-Zapien

Affiliations

Soon will be listed here.

Abstract

Introduction: The acute kidney injury (AKI) is characterized by a sudden glomerular filtration reduction. Renal or intrinsic causes of AKI include nephrotoxicity induced by exogenous agents like cisplatin, which causes oxidative stress altering the biochemical process and leading to apoptosis. Therefore, this research is aimed at analyzing the embryonic stem cells (ESC) nephroprotective effect in AKI induced by cisplatin, employing genetic, phenotypic, and microspectroscopic techniques.

Methods: Thirty mice were randomly divided into three groups ( = 10): the healthy, isotonic salt solution (ISS), and mouse embryonic stem cells (mESC) groups. The ISS and mESC groups were subjected to AKI using cisplatin; 24 h post-AKI received an intraperitoneal injection of ISS or 1 × 10 mESC, respectively. At days 4 and 8 post-AKI, five mice of each group were sacrificed to analyze the histopathological, genetic ( and ), protein (p53), and vibrational microspectroscopic changes.

Results: Histopathologically, interstitial nephritis and acute tubular necrosis were observed; however, the mESC group showed a more preserved microarchitecture with high cellularity. Additionally, the PDK4 and HO-1 gene expression only increased in the ISS group on day 4 post-AKI. Likewise, p53 was more immunoexpressed at day 8 post-AKI in the ISS group. About biomolecular analysis by microspectroscopy, bands associated with lipids, proteins, and nucleic acids were evidenced. Besides, ratios related to membrane function (protein/lipid), unsaturated lipid content (olefinic/total lipid, olefinic/total CH, and CH/CH), and lipid peroxidation demonstrated oxidative stress induction and lipid peroxidation increase mainly in the ISS group. Finally, the principal component analysis discriminated against each group; nonetheless, some data of the healthy and mESC groups at day 8 were correlated.

Conclusions: The mESC implant diminishes cisplatin nephrotoxicity, once the protective effect in the reduction of lipid peroxidation was demonstrated, reflecting a functional and histological restoration.

Citing Articles

Exploring the role and therapeutic potential of lipid metabolism in acute kidney injury.

Zhang X, Wu W, Li Y, Peng Z Ren Fail. 2024; 46(2):2403652.

PMID: 39319697 PMC: 11425701. DOI: 10.1080/0886022X.2024.2403652.

Therapeutic potential of urine-derived stem cells in renal regeneration following acute kidney injury: A comparative analysis with mesenchymal stem cells.

Li F, Zhao B, Zhang L, Chen G, Zhu L, Feng X World J Stem Cells. 2024; 16(5):525-537.

PMID: 38817335 PMC: 11135250. DOI: 10.4252/wjsc.v16.i5.525.

The underlying mechanisms of cisplatin-induced nephrotoxicity and its therapeutic intervention using natural compounds.

Zhang D, Luo G, Jin K, Bao X, Huang L, Ke J Naunyn Schmiedebergs Arch Pharmacol. 2023; 396(11):2925-2941.

PMID: 37289283 DOI: 10.1007/s00210-023-02559-6.

Zooming in and out of ferroptosis in human disease.

Wang X, Zhou Y, Min J, Wang F Front Med. 2023; 17(2):173-206.

PMID: 37121959 DOI: 10.1007/s11684-023-0992-z.

Abnormal Iron and Lipid Metabolism Mediated Ferroptosis in Kidney Diseases and Its Therapeutic Potential.

Zhang X, Li X Metabolites. 2022; 12(1).

PMID: 35050181 PMC: 8779729. DOI: 10.3390/metabo12010058.

References

Agarwal A, Nick H . Renal response to tissue injury: lessons from heme oxygenase-1 GeneAblation and expression. J Am Soc Nephrol. 2000; 11(5):965-973. DOI: 10.1681/ASN.V115965. View

Shiraishi F, Curtis L, Truong L, Poss K, Visner G, Madsen K . Heme oxygenase-1 gene ablation or expression modulates cisplatin-induced renal tubular apoptosis. Am J Physiol Renal Physiol. 2000; 278(5):F726-36. DOI: 10.1152/ajprenal.2000.278.5.F726. View

Lee S, Lumelsky N, Studer L, Auerbach J, McKay R . Efficient generation of midbrain and hindbrain neurons from mouse embryonic stem cells. Nat Biotechnol. 2000; 18(6):675-9. DOI: 10.1038/76536. View

Sugden M, Lall H, Harris R, Holness M . Selective modification of the pyruvate dehydrogenase kinase isoform profile in skeletal muscle in hyperthyroidism: implications for the regulatory impact of glucose on fatty acid oxidation. J Endocrinol. 2000; 167(2):339-45. DOI: 10.1677/joe.0.1670339. View

Cummings B, Schnellmann R . Cisplatin-induced renal cell apoptosis: caspase 3-dependent and -independent pathways. J Pharmacol Exp Ther. 2002; 302(1):8-17. DOI: 10.1124/jpet.302.1.8. View

Schaaf G, Maas R, de Groene E, Fink-Gremmels J . Management of oxidative stress by heme oxygenase-1 in cisplatin-induced toxicity in renal tubular cells. Free Radic Res. 2002; 36(8):835-43. DOI: 10.1080/1071576021000005267. View

Vaziri N, Sato T, Liang K . Molecular mechanisms of altered cholesterol metabolism in rats with spontaneous focal glomerulosclerosis. Kidney Int. 2003; 63(5):1756-63. DOI: 10.1046/j.1523-1755.2003.00911.x. View

Vaziri N . Molecular mechanisms of lipid disorders in nephrotic syndrome. Kidney Int. 2003; 63(5):1964-76. DOI: 10.1046/j.1523-1755.2003.00941.x. View

Prinsen B, de Sain-van der Velden M, de Koning E, Koomans H, Berger R, Rabelink T . Hypertriglyceridemia in patients with chronic renal failure: possible mechanisms. Kidney Int Suppl. 2003; (84):S121-4. DOI: 10.1046/j.1523-1755.63.s84.34.x. View

10.

Sachinidis A, Fleischmann B, Kolossov E, Wartenberg M, Sauer H, Hescheler J . Cardiac specific differentiation of mouse embryonic stem cells. Cardiovasc Res. 2003; 58(2):278-91. DOI: 10.1016/s0008-6363(03)00248-7. View

11.

Portilla D . Energy metabolism and cytotoxicity. Semin Nephrol. 2003; 23(5):432-8. DOI: 10.1016/s0270-9295(03)00088-3. View

12.

Li S, Wu P, Yarlagadda P, Vadjunec N, Proia A, Harris R . PPAR alpha ligand protects during cisplatin-induced acute renal failure by preventing inhibition of renal FAO and PDC activity. Am J Physiol Renal Physiol. 2003; 286(3):F572-80. DOI: 10.1152/ajprenal.00190.2003. View

13.

Schrier R, Wang W, Poole B, Mitra A . Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest. 2004; 114(1):5-14. PMC: 437979. DOI: 10.1172/JCI22353. View

14.

Jiang M, Yi X, Hsu S, Wang C, Dong Z . Role of p53 in cisplatin-induced tubular cell apoptosis: dependence on p53 transcriptional activity. Am J Physiol Renal Physiol. 2004; 287(6):F1140-7. DOI: 10.1152/ajprenal.00262.2004. View

15.

Togel F, Hu Z, Weiss K, Isaac J, Lange C, Westenfelder C . Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am J Physiol Renal Physiol. 2005; 289(1):F31-42. DOI: 10.1152/ajprenal.00007.2005. View

16.

Taguchi T, Nazneen A, Abid M, Razzaque M . Cisplatin-associated nephrotoxicity and pathological events. Contrib Nephrol. 2005; 148:107-121. DOI: 10.1159/000086055. View

17.

Schena F, Gesualdo L . Pathogenetic mechanisms of diabetic nephropathy. J Am Soc Nephrol. 2005; 16 Suppl 1:S30-3. DOI: 10.1681/asn.2004110970. View

18.

Liu K, Man A, Shaw R, Liang B, Xu Z, Gong Y . Molecular determination of liver fibrosis by synchrotron infrared microspectroscopy. Biochim Biophys Acta. 2006; 1758(7):960-7. DOI: 10.1016/j.bbamem.2006.05.006. View

19.

Schroeder I, Rolletschek A, Blyszczuk P, Kania G, Wobus A . Differentiation of mouse embryonic stem cells to insulin-producing cells. Nat Protoc. 2007; 1(2):495-507. DOI: 10.1038/nprot.2006.71. View

20.

Negishi K, Noiri E, Sugaya T, Li S, Megyesi J, Nagothu K . A role of liver fatty acid-binding protein in cisplatin-induced acute renal failure. Kidney Int. 2007; 72(3):348-58. DOI: 10.1038/sj.ki.5002304. View